SeaStar Medical Holding Corp (ICU): Nasdaq/NYSE listing notice — SeaStar Medical regains Nasdaq market value rule; still below $1 bid; hearing Mar 12

SeaStar Medical Holding Corp

Regained compliance with Nasdaq Market Value Rule ($35M minimum) as of Feb 6, 2024.
Remains non-compliant with Minimum Bid Price Rule ($1.00) for 30+ business days.
Hearing before Nasdaq Hearings Panel scheduled March 12, 2024 to present cure plan.
Common stock continues trading on Nasdaq Capital Market under 'ICU' pending Panel decision.

item 3.01

Key facts

Extracted from this filing and checked against the source text.

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

SeaStar Medical Holding Corp received a nasdaq hearing update notice regarding minimum bid price (rules 5550(a)(2)).

Exchange: nasdaq
Notice: hearing update
Deficiency: minimum bid price
Rules: 5550(a)(2)

Exact text from the filing

February 6, 2024, the Company received notification from the Staff that the Company had regained compliance with the Market Value Rule. However, the Staff indicated the Company remains non-compliant with the Minimum Bid Price Rule and therefore, as previously disclosed, the Company should present its views with respect to this deficiency at its scheduled hearing in front of the Nasdaq Hearings Panel (the “Panel”) on March 12, 2024 (the “ Hearing ”). At the hearing, the Company will present its plan to regain compliance with the Minimum Bid Price Rule. Subject to the final written decision by t

View on SEC.gov

Listing & Compliance Notices SEC 8-K Item 3.01 confidence 0.9

SeaStar Medical Holding Corp received a nasdaq compliance regained notice regarding market value (rules 5550(b)(2)).

Exchange: nasdaq
Notice: compliance regained
Deficiency: market value
Rules: 5550(b)(2)

Exact text from the filing

February 6, 2024, the Company received notification from the Staff that the Company had regained compliance with the Market Value Rule. However, the Staff indicated the Company remains non-compliant with the Minimum Bid Price Rule and therefore, as previously disclosed, the Company should present its views with respect to this deficiency at its scheduled hearing in front of the Nasdaq Hearings Panel (the “Panel”) on March 12, 2024 (the “ Hearing ”). At the hearing, the Company will present its plan to regain compliance with the Minimum Bid Price Rule. Subject to the final written decision by t

View on SEC.gov

Browse all listing & compliance notices →

SeaStar Medical Holding Corp filing history →

Source: SEC EDGAR

accession 0000950170-24-013257

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.